Month: August 2020

Dallas, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $9.1 million, or $.32 per diluted share, in the second quarter of 2020 compared to net income of  $7.1 million, or $.25 per diluted share, in the second quarter of 2019. For the first six months of 2020, Valhi reported net income attributable to Valhi stockholders of $15.3 million, or $.54 per diluted share compared to net income of $25.3 million, or $.89 per diluted share in the first six months of 2019.  Net income attributable to Valhi stockholders decreased in the second quarter of 2020 as compared to the second quarter of 2019 due to the net effects of lower operating results from all of our segments, a higher effective income tax rate in 2020 and lower litigation settlement expenses in 2020 due...

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® technology platform, today reported second quarter 2020 financial results and provided a business update.“CytomX made broad progress across our clinical and preclinical programs during the second quarter as we further advanced our technology platform, partnerships, and lead drug candidates to several important inflection points,” said Sean McCarthy, D.Phil., president, chief executive officer and chairman of CytomX Therapeutics. “We continue to show leadership in defining new therapeutic antibody modalities with demonstrated potential to address significant unmet medical needs in the...

SAN JOSE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE: CWT) today announced awards totaling $80,000 in college scholarships for students living in the utility’s California, Hawaii, New Mexico, and Washington service areas for the 2020-2021 academic year.Group selected 12 students for the upcoming academic year; winners were chosen based on outstanding academic achievement, community service, and financial need. Many of the recipients are first-generation college attendees. Four grand-prize recipients were awarded $10,000 scholarships:AiYi Chen, of Stockton, Calif., attends San Jose State University and is studying business administration and accounting.Natalya Chun, from San Mateo, Calif., will attend New York University and will study global and liberal studies.Alejandro Gaytan, of...

HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) — Crown Castle International Corp. (NYSE: CCI) (“Crown Castle”) announced today that its Board of Directors has declared a quarterly cash dividend of $1.20 per common share.  The quarterly dividend will be payable on September 30, 2020 to common stockholders of record at the close of business on September 15, 2020.  Future dividends are subject to the approval of the Company’s Board of Directors. ABOUT CROWN CASTLECrown Castle owns, operates and leases more than 40,000 cell towers and approximately 80,000 route miles of fiber supporting small cells and fiber solutions across every major U.S. market. This nationwide portfolio of communications infrastructure connects cities and communities to essential data, technology and wireless service – bringing information, ideas and innovations...

Allentown, PA, Aug. 06, 2020 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Second Quarter 2020 ResultsReported Second Quarter 2020 Operating Income of $6.3 million and Net Income of $5.2 million compared to Operating Income of $13.9 million and Net Income of $6.4 million for the Second Quarter 2019Generated Second Quarter 2020 Adjusted EBITDA of $27.7 million and Distributable Cash Flow of $26.0 million compared to Second Quarter 2019 Adjusted EBITDA of $27.7 million and Distributable Cash Flow of $22.3 millionReported Second Quarter 2020 Gross Profit for the Wholesale Segment of $40.7 million compared to $33.4 million of Gross Profit for the Second Quarter 2019Reported Second Quarter 2020 Gross Profit for the Retail Segment of $15.9 million compared to $8.1 million of Gross Profit for the Second Quarter 2019Distributed 260.2...

CALHOUN, Ga., Aug. 06, 2020 (GLOBE NEWSWIRE) — Mohawk Industries, Inc. (NYSE: MHK) today announced a 2020 second quarter net loss of $48 million and diluted loss per share of $0.68. Adjusted net earnings were $26 million, and earnings per share (EPS) was $0.37, excluding restructuring, acquisition and other charges. Net sales for the second quarter of 2020 were $2.0 billion, down 21% as reported and 19% on a constant currency basis. For the second quarter of 2019, net sales were $2.6 billion, net earnings were $202 million and EPS was $2.79, adjusted net earnings were $210 million, and EPS was $2.89, excluding restructuring, acquisition and other charges.For the six months ending June 27, 2020, net earnings and EPS were $62 million and $0.87, respectively. Net earnings excluding restructuring, acquisition and other charges were...

TAMPA, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, reported results for the three and six months ended June 30, 2020.Second Quarter 2020 – Financial ResultsNet income for the second quarter of 2020 totaled $8.9 million or $1.08 diluted earnings per share compared with $7.6 million or $0.90 diluted earnings per share in the second quarter of 2019. Adjusted net income (a non-GAAP measure which excludes net unrealized gains or losses on equity securities) for the quarter was $6.8 million or $0.86 diluted earnings per share compared with $6.6 million or $0.81 diluted earnings per share in the second quarter of 2019. The company has included in this press release an explanation of adjusted net income as well as a reconciliation...

Board of Directors authorizes $75 million share repurchase programProceeds from sale of ALG used to support this repurchase program, fortify balance sheet and maintain strategic flexibilitySANTA MONICA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — TrueCar, Inc. (NASDAQ: TRUE), the most efficient and transparent online destination to find a car, announced today that it has entered into an agreement with J.D. Power to sell its ALG, Inc. subsidiary for $135 million. The total consideration includes an upfront cash payment of $112.5 million at closing and total deferred payments of up to $22.5 million based on certain financial results.TrueCar also announced that its Board of Directors has authorized a share repurchase program of up to $75 million, with the intent to begin repurchasing shares in the near-term. The company intends to use...

SANTA MONICA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — TrueCar, Inc. (NASDAQ: TRUE) today announced its financial results for the second quarter ended June 30, 2020.Second Quarter 2020 Financial HighlightsSecond quarter total revenue of $62.7 million, down (28.8)% from a year ago.Second quarter net loss of $(11.2) million, or $(0.10) per share, compared to net loss of $(24.1) million, or $(0.23) per share, in the second quarter of 2019.Second quarter Non-GAAP net income(1) of $4.4 million, or $0.04 per share, compared to Non-GAAP net loss of $(2.2) million, or $(0.02) per share, in the second quarter of 2019.Second quarter Adjusted EBITDA(2) of $10.9 million, representing an Adjusted EBITDA margin(3) of 17.4%, compared to Adjusted EBITDA of $3.7 million, representing an Adjusted EBITDA margin of 4.1%, in the second quarter of 2019.$173.1...

BELTSVILLE, Md., Aug. 06, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today reported second quarter 2020 financial results and provided a business update.“Despite our recent announcement that we did not see sufficient clinical activity required for advancement in our initial non-small cell lung cancer and ovarian cancer Phase 2 cohorts, we remain encouraged about the NC318 single agent activity we have seen in patients with both non-small cell lung and head and neck cancers. We are working diligently in hopes of better understanding Siglec-15 biology and evaluating biomarkers that may provide a focused path forward. We anticipate having more information...